Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2018-03-05
2021-12-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantification of Endothelial Thrombogenicity in Patients With Atrial Fibrillation
NCT02756429
Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation
NCT05961865
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias
NCT05965375
Study of the Expression of Autophagy Markers in the Myocardium in Patients With Persistent or Permanent Atrial Fibrillation
NCT05850039
Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT02208102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Persistent AF
Peripheral Blood Sample
30mL peripheral whole blood sample
Paroxysmal AF
Peripheral Blood Sample
30mL peripheral whole blood sample
Psoriasis
Peripheral Blood Sample
30mL peripheral whole blood sample
Healthy Controls
Peripheral Blood Sample
30mL peripheral whole blood sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peripheral Blood Sample
30mL peripheral whole blood sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Controls 1: (No prior history of AF or inflammatory or autoimmune diseases)
* Controls 2: (biopsy proven Psoriasis)
Exclusion Criteria
* Chronic infections
* Recent malignancies
* Recent Radiation or chemotherapy
* Chronic kidney disease (≥ stage 2)
* Organ transplantation
* History of chronic liver disease
* Major surgery or invasive procedure in the past 6 months
* Internal prosthesis
* Receiving immunosuppressive therapy
* Known rheumatologic diseases (except for the participants with psoriasis)
* Females who are known to be pregnant
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rowlens M. Melduni
Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rowlens M. Melduni, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-005678
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.